Skip to main content
. 2021 Jul 9;5:PO.21.00039. doi: 10.1200/PO.21.00039

FIG 2.

FIG 2.

Kinetics of molecular response of blast phase chronic myeloid leukemia with the addition of blinatumomab to ponatinib. Labels on the x-axis indicate the start time of therapy. CMR, complete molecular remission; HCT, hematopoietic cell transplant; HyperCVAD, hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone; IS, International Scale; MMR, major molecular response.